Keyur S. Vyas

Professor

UAMS

Also affiliated: University of Kentucky (2016); University of Arkansas Medical Center (2025); Massachusetts General Hospital (2015); Central Arkansas Veterans Healthcare System (2007–2011); Office of Infectious Diseases (2014)

Faculty Researcher

Internal Med, College of Medicine

9 h-index 30 pubs 285 cited

Research Areas

Biomedical Subjects

Links

Research Group UAMS TRI Profile

OverviewAI-generated summary

Keyur S. Vyas, Professor of Internal Medicine at the University of Arkansas for Medical Sciences, studies infectious diseases and public health trends within Arkansas. His research has focused on various aspects of COVID-19, including disparities in symptomatology and outcomes based on gender and race, as well as associated conditions like mucormycosis. He has investigated healthcare-associated outbreaks and the impact of the pandemic on supplement usage and self-medication in the state. Vyas's work also includes case series and reviews on less common conditions, such as hemorrhagic encephalitis in COVID-19 patients and Takayasu aortitis. His scholarly output includes 30 publications, with an h-index of 9 and 282 citations. He has collaborated with researchers including Wendy N. Nembhard, Benjamin C. Amick, and Emine Bircan.

Metrics

h-index: 9
Publications: 30
Citations: 285

Selected Publications

Hydrocortisone Use for Septic Shock in Patients With CKD (2026)

Kidney International Reports DOI OpenAlex
Atypical Case of Takayasu Aortitis Presenting as Embolic Stroke With Concomitant Massive Thoracic Artery Aneurysm (2026)

Clinical Case Reports DOI OpenAlex
Use of Aztreonam–Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing Enterobacter cloacae (2025)

Antibiotics 2 citations DOI OpenAlex
Gender disparities in symptomology of COVID-19 among adults in Arkansas (2023)

Preventive Medicine Reports 10 citations DOI OpenAlex
Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital—Arkansas, June 2019–May 2021 (2022)

Open Forum Infectious Diseases 8 citations DOI OpenAlex
Analysis of COVID-19 Pandemic on Supplement Usage and Its Combination with Self-Medication within the State of Arkansas (2022)

Journal of Dietary Supplements 12 citations DOI OpenAlex
Racial disparities in symptomatology and outcomes of COVID-19 among adults of Arkansas (2022)

Preventive Medicine Reports 10 citations DOI OpenAlex
Spectrum of Hemorrhagic Encephalitis in COVID-19 Patients: A Case Series and Review (2022)

Diagnostics 9 citations DOI OpenAlex
<i>Notes from the Field:</i> COVID-19–Associated Mucormycosis — Arkansas, July–September 2021 (2021)

MMWR Morbidity and Mortality Weekly Report 21 citations DOI OpenAlex
Bloodstream Infections With a Novel Nontuberculous Mycobacterium Involving 52 Outpatient Oncology Clinic Patients―Arkansas, 2018 (2019)

Clinical Infectious Diseases 6 citations DOI OpenAlex
613: DOUBLE WHAMMY: ESCHERICHIA COLI SUPPURATIVE THYROIDITIS AND HIV-ASSOCIATED NEPHROPATHY (2018)

Critical Care Medicine DOI OpenAlex
Mobilizing a Statewide Network to Provide Ebola Education and Support (2015)

Telemedicine Journal and e-Health 7 citations DOI OpenAlex
Pulmonary Blastomycosis (2011)

Seminars in Respiratory and Critical Care Medicine 37 citations DOI OpenAlex
Treatment of endemic mycoses (2010)

Expert Review of Respiratory Medicine 6 citations DOI OpenAlex
Alkaline Phosphatase (AP) and Gamma Glutamyl-Transpeptidase (GGT) Elevations in Patients with Histoplasmosis (Histo) (2008)

46th Annual Meeting OpenAlex